130 related articles for article (PubMed ID: 16172243)
21. Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk.
Nam RK; Trachtenberg J; Jewett MA; Toi A; Evans A; Emami M; Narod SA; Pollak M
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1270-3. PubMed ID: 15894684
[TBL] [Abstract][Full Text] [Related]
22. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
Tworoger SS; Lee IM; Buring JE; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1691-5. PubMed ID: 17684148
[TBL] [Abstract][Full Text] [Related]
24. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
[TBL] [Abstract][Full Text] [Related]
25. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
Hong SK; Han BK; Jeong JS; Jeong SJ; Moon KH; Byun SS; Lee SE
Asian J Androl; 2008 Mar; 10(2):207-13. PubMed ID: 18097534
[TBL] [Abstract][Full Text] [Related]
26. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
[TBL] [Abstract][Full Text] [Related]
27. Association of insulin-like growth factor I and insulin-like growth factor-binding protein-3 with intelligence quotient among 8- to 9-year-old children in the Avon Longitudinal Study of Parents and Children.
Gunnell D; Miller LL; Rogers I; Holly JM;
Pediatrics; 2005 Nov; 116(5):e681-6. PubMed ID: 16263982
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence?
Meinbach DS; Lokeshwar BL
Urol Oncol; 2006; 24(4):294-306. PubMed ID: 16818181
[TBL] [Abstract][Full Text] [Related]
29. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Xue X; Kritchevsky SB; Newman AB; Psaty BM
J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
[TBL] [Abstract][Full Text] [Related]
30. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study.
Hunt KJ; Lukanova A; Rinaldi S; Lundin E; Norat T; Palmqvist R; Stattin P; Riboli E; Hallmans G; Kaaks R
Ann Epidemiol; 2006 Jul; 16(7):563-71. PubMed ID: 16431135
[TBL] [Abstract][Full Text] [Related]
31. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
Vatten LJ; Holly JM; Gunnell D; Tretli S
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2097-100. PubMed ID: 18708402
[TBL] [Abstract][Full Text] [Related]
32. A nested case-control study of stomach cancer and serum insulin-like growth factor (IGF)-1, IGF-2 and IGF-binding protein (IGFBP)-3.
Pham TM; Fujino Y; Kikuchi S; Tamakoshi A; Yatsuya H; Matsuda S; Yoshimura T;
Eur J Cancer; 2007 Jul; 43(10):1611-6. PubMed ID: 17532620
[TBL] [Abstract][Full Text] [Related]
33. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial.
Meyer F; Galan P; Douville P; Bairati I; Kegle P; Bertrais S; Estaquio C; Hercberg S
Int J Cancer; 2005 Aug; 116(2):182-6. PubMed ID: 15800922
[TBL] [Abstract][Full Text] [Related]
34. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center.
Kurahashi N; Iwasaki M; Inoue M; Sasazuki S; Tsugane S
J Clin Oncol; 2008 Dec; 26(36):5923-9. PubMed ID: 19018085
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the components of the insulin-like growth factors system in GH-deficient adults: effects of twelve-month rhGH treatment.
Ferrante E; Giavoli C; Porretti S; Vassallo E; Ronchi CL; Lania AG; Beck-Peccoz P; Spada A
Horm Metab Res; 2006 May; 38(5):352-5. PubMed ID: 16718634
[TBL] [Abstract][Full Text] [Related]
36. Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
Mu L; Katsaros D; Wiley A; Lu L; de la Longrais IA; Smith S; Khubchandani S; Sochirca O; Arisio R; Yu H
Breast Cancer Res Treat; 2009 May; 115(1):151-62. PubMed ID: 18481170
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
Berrigan D; Potischman N; Dodd KW; Nicar M; McQuillan G; Lavigne JA; Barrett JC; Ballard-Barbash R
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
[TBL] [Abstract][Full Text] [Related]
38. Prediagnostic plasma vascular endothelial growth factor levels and risk of prostate cancer.
Li H; Kantoff PW; Ma J; Stampfer MJ; George DJ
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1557-61. PubMed ID: 15941972
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the IGF system in 15 patients with Alström syndrome.
Maffei P; Boschetti M; Marshall JD; Paisey RB; Beck S; Resmini E; Collin GB; Naggert JK; Milan G; Vettor R; Minuto F; Sicolo N; Barreca A
Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998
[TBL] [Abstract][Full Text] [Related]
40. No effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancer.
Vrieling A; Rookus MA; Kampman E; Bonfrer JM; Bosma A; Cats A; van Doorn J; Korse CM; Witteman BJ; van Leeuwen FE; van't Veer LJ; Voskuil DW
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2585-93. PubMed ID: 18842999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
